“…The other alteration observed concerns the RBFOX1 gene, which is located on chromosome 16, cytoband p13.3 (5,239,738-7,713,340 (GRCh38/hg38), and includes 25 exons for a total length of about 2,473,603 bases, with 40 transcripts and 178 orthologues. RBFOX1 is a dose-sensitive gene that encodes splicing factors specifically expressed in neurons and muscles and is an important regulator of development and neuronal excitability [ 29 , 30 , 31 ]. Reduced RBFOX1 expression has been associated with neurodevelopmental disorders; indeed, CNVs comprising RBFOX1 are implicated in mental retardation, epilepsy, schizoaffective disorder (SCZ) [ 29 , 32 ], bipolar disorder (BD), attention deficit hyperactivity disorder (ADHD), ID [ 33 ] and ASD [ 34 ].…”